Device
Erbium:YAG Laser
Erbium:YAG Laser is a medical device with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Active, not recruiting1
Recruiting1
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
active_not_recruiting133%
recruiting133%
enrolling_by_invitation133%
Recent Activity
2 active trials
Showing 3 of 3
enrolling_by_invitationphase_2
Treatment of Sebaceous Hyperplasia With PDL and Nd:YAG Versus Erbium:YAG: A Randomized Controlled Trial
NCT04429607
active_not_recruitingnot_applicable
Comparative Effects Of Trichloroacetic Chemical Peel And Fractional Laser
NCT07036302
recruitingnot_applicable
Lasertherapy for Vulvodynia
NCT04711369
Clinical Trials (3)
Showing 3 of 3 trials
NCT04429607Phase 2
Treatment of Sebaceous Hyperplasia With PDL and Nd:YAG Versus Erbium:YAG: A Randomized Controlled Trial
NCT07036302Not Applicable
Comparative Effects Of Trichloroacetic Chemical Peel And Fractional Laser
NCT04711369Not Applicable
Lasertherapy for Vulvodynia
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3